NovoCure Shares Outstanding 2014-2023 | NVCR
NovoCure shares outstanding from 2014 to 2023. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
| NovoCure Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2023 | 106 |
| 2022 | 105 |
| 2021 | 103 |
| 2020 | 109 |
| 2019 | 97 |
| 2018 | 92 |
| 2017 | 89 |
| 2016 | 86 |
| 2015 | 30 |
| 2014 | 12 |
| 2013 | 11 |
| NovoCure Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2023-12-31 | 106 |
| 2023-09-30 | 107 |
| 2023-06-30 | 106 |
| 2023-03-31 | 106 |
| 2022-12-31 | 105 |
| 2022-09-30 | 105 |
| 2022-06-30 | 105 |
| 2022-03-31 | 104 |
| 2021-12-31 | 103 |
| 2021-09-30 | 104 |
| 2021-06-30 | 103 |
| 2021-03-31 | 103 |
| 2020-12-31 | 109 |
| 2020-09-30 | 109 |
| 2020-06-30 | 108 |
| 2020-03-31 | 108 |
| 2019-12-31 | 97 |
| 2019-09-30 | 108 |
| 2019-06-30 | 96 |
| 2019-03-31 | 95 |
| 2018-12-31 | 92 |
| 2018-09-30 | 93 |
| 2018-06-30 | 91 |
| 2018-03-31 | 90 |
| 2017-12-31 | 89 |
| 2017-09-30 | 89 |
| 2017-06-30 | 88 |
| 2017-03-31 | 87 |
| 2016-12-31 | 86 |
| 2016-09-30 | 86 |
| 2016-06-30 | 85 |
| 2016-03-31 | 84 |
| 2015-12-31 | 30 |
| 2015-09-30 | 12 |
| 2015-06-30 | |
| 2015-03-31 | 13 |
| 2014-12-31 | |
| 2014-09-30 | 13 |
| 2013-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $1.453B | $0.509B |
| NovoCure Limited is an oncology company. The Company is engaged in developing a therapy called Tumor Treating Fields for the treatment of solid tumor cancers. It operates primarily in the United States, Germany, Switzerland and Japan. NovoCure Limited is based in Saint Helier, Channel Islands. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $115.766B | 15.02 |
| Cencora (COR) | United States | $46.679B | 18.63 |
| ICON (ICLR) | Ireland | $25.244B | 24.90 |
| DiDi Global (DIDIY) | China | $23.367B | 0.00 |
| Avantor (AVTR) | United States | $16.930B | 23.33 |
| CochLear (CHEOY) | $13.697B | 0.00 | |
| Viatris (VTRS) | United States | $13.592B | 3.88 |
| Revvity (RVTY) | United States | $12.784B | 22.26 |
| Charles River Laboratories (CRL) | United States | $12.432B | 22.66 |
| Medpace Holdings (MEDP) | United States | $12.238B | 44.48 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.209B | 0.00 |
| Natera (NTRA) | United States | $11.408B | 0.00 |
| Solventum (SOLV) | $10.825B | 0.00 | |
| Amplifon S.p.A (AMFPF) | Italy | $7.290B | 37.01 |
| HealthEquity (HQY) | United States | $6.851B | 51.19 |
| Bausch + Lomb (BLCO) | Canada | $4.998B | 19.24 |
| Doximity (DOCS) | United States | $4.826B | 35.93 |
| Organon (OGN) | United States | $4.461B | 4.32 |
| Surgery Partners (SGRY) | United States | $3.334B | 30.98 |
| Progyny (PGNY) | United States | $3.300B | 55.16 |
| Sotera Health (SHC) | United States | $3.193B | 15.67 |
| Life Times (LTH) | United States | $2.817B | 31.13 |
| GoodRx Holdings (GDRX) | United States | $2.698B | 136.60 |
| Premier (PINC) | United States | $2.527B | 9.25 |
| Teladoc Health (TDOC) | United States | $2.406B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $2.146B | 6.94 |
| Agilon Health (AGL) | United States | $2.027B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $1.720B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.381B | 0.00 | |
| Agiliti (AGTI) | United States | $1.366B | 22.33 |
| Alignment Healthcare (ALHC) | United States | $0.888B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.776B | 8.03 |
| Embecta (EMBC) | United States | $0.590B | 3.90 |
| Auna S.A (AUNA) | Luxembourg | $0.569B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.536B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.531B | 0.00 |
| Enhabit (EHAB) | United States | $0.522B | 47.27 |
| MultiPlan (MPLN) | United States | $0.507B | 0.00 |
| Beauty Health (SKIN) | United States | $0.452B | 0.00 |
| CareDx (CDNA) | United States | $0.442B | 0.00 |
| LifeMD (LFMD) | United States | $0.390B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.370B | 0.00 |
| DocGo (DCGO) | United States | $0.340B | 54.33 |
| ModivCare (MODV) | United States | $0.319B | 4.23 |
| Sera Prognostics (SERA) | United States | $0.313B | 0.00 |
| Sharecare (SHCR) | United States | $0.266B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.252B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.251B | 0.00 |
| Biodesix (BDSX) | United States | $0.119B | 0.00 |
| So-Young (SY) | China | $0.116B | 39.00 |
| Oncology Institute (TOI) | United States | $0.095B | 0.00 |
| Pono Capital Two (PTWO) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| NeueHealth (NEUE) | United States | $0.050B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.040B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.038B | 0.00 |
| Nutex Health (NUTX) | United States | $0.033B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.032B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.031B | 0.00 |
| OncoCyte (OCX) | United States | $0.022B | 0.00 |
| DermTech (DMTK) | United States | $0.022B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.014B | 0.00 |
| BIMI Medical (BIMI) | United States | $0.012B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.012B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.009B | 0.00 |
| OpGen (OPGN) | United States | $0.007B | 0.00 |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Assure Holdings (IONM) | United States | $0.005B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |